NOVOCART 3D Treatment Following Microfracture Failure
Clinical trial NCT03219307 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03219307
- Sponsor
- Aesculap Biologics, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-30
- Primary completion
- 2026-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.